AnaptysBio to Drop Eczema Drug Candidate After Trials Miss Endpoints; Shares Fall

AnaptysBio将在试验未能达成终点后放弃湿疹药物候选者; 股价下跌

WSJ · 12/11 22:36

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.